Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. Jos\u00e9 Luis Latorre<\/p>\n
Inbiotec Medical Devices, the new line of healthcare products developed by the IT Pharma group, is bringing its first product to market: Inbiotec Amber, a new injectable comprising 1.1% hyaluronic acid and 1.6% succinic acid. In a paper entitled: A new concept in mesotherapy: Discover the benefits of succinic acid, Doctor Latorre will explain the benefits of this active ingredient sourced from amber.<\/strong><\/p>\n With this new line of healthcare products for aestheticians and dermatologists, IT Pharma aims to provide professionals with a safe, innovative product that stands out due to its combination of top quality ingredients.<\/p>\n The presentation is set to take place on Friday 22nd in Malaga, Conference Room 1 and will count on the presence of Dr. Pilar Garcia-Las Heras as moderator.<\/p>\n \t\t\t\t\t\t\t\tShare on twitter<\/p>\n \t\t\t\t\t\t\t\tShare on linkedin<\/p>\n Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. Jos\u00e9 Luis Latorre<\/p>\n","protected":false},"author":78,"featured_media":12626,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"Inbiotec Amber: hyaluronic with succinic acid, the new injectable by IT Pharma","_seopress_titles_desc":"Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. Jos\u00e9 Luis Latorre","_seopress_robots_index":"","footnotes":""},"categories":[1308],"tags":[1312,1314],"class_list":{"0":"post-13118","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-uncategorized-en","8":"tag-succinic-en","9":"tag-succinic-acid-en"},"_links":{"self":[{"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/posts\/13118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/users\/78"}],"replies":[{"embeddable":true,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13118"}],"version-history":[{"count":1,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/posts\/13118\/revisions"}],"predecessor-version":[{"id":33715,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/posts\/13118\/revisions\/33715"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/media\/12626"}],"wp:attachment":[{"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Make a comment<\/h4>\n
Follow us on FB<\/h4>\n","protected":false},"excerpt":{"rendered":"